Concepedia

Author

Erik J.M. van Bommel

Amsterdam University Medical CentersORCID

Also Known As

E.J.M. van Bommel, ERIK J. VAN BOMMEL, ERIK J.M. VAN BOMMEL, Erik J M van Bommel, Erik J. M. van Bommel, Erik J. van Bommel, Erik J.M. Bommel, Erik J.M. van Bommel, Erik JM van Bommel, Erik J.M. van Bommel

26

Publications

1.8K

Citations

12

H-Index

18

Concepts

All Affiliations

Amsterdam University Medical CentersUniversity Medical Center UtrechtUniversity Medical Center GroningenUniversity of GroningenErasmus MC
EJ

About

Erik J.M. van Bommel is an author at Amsterdam University Medical Centers specializing in diabetes, medicine, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

432

2

Diabetes

3

3

432

3

Health Sciences

2

2

352

4

Endocrinology

1

1

21

5

Microbiology

1

1

80

Erik J.M. van Bommel

×

7

Publications

521

Citations

7

H-Index

YearCitations

The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial

Erik J.M. van Bommel, Marcel H.A. Muskiet, Michaël J.B. van Baar,

Kidney International

2019

331

Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes

Erik J.M. van Bommel, Hilde Herrema, Mark Davids,

Diabetes & Metabolism

2019

80

Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes

Erik J.M. van Bommel, Mark M. Smits, Danique Ruiter,

Journal of Hypertension

2020

30

SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid–base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes

Erik J.M. van Bommel, Frank Geurts, Marcel H.A. Muskiet,

Clinical Science

2020

30

The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trial

Erik J.M. van Bommel, Renate T. de Jongh, Annemieke C. Heijboer,

Bone

2018

21

Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function

Erik J.M. van Bommel, Danique Ruiter, Marcel H.A. Muskiet,

Diabetes Care

2019

17

The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol

Kristien E. Bouter, Erik J.M. van Bommel, Hans Jansen,

Diabetes Obesity and Metabolism

2020

12

Page 1